1-15 of 17
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Jennifer Caudle, DO, FACOFP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
Debunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Medical Industry FeatureDebunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Clay Jackson, MD
Amita Patel, MD, CMD
Expandable Cages Enhance Minimally Invasive Spinal Fusion
Medical Industry FeatureExpandable Cages Enhance Minimally Invasive Spinal Fusion
Ibrahim Hussain, M.D.
Engaging Neuroplasticity in Depression with Cognitive-Emotional Training
Medical Industry FeatureEngaging Neuroplasticity in Depression with Cognitive-Emotional Training
Charles Turck, PharmD, BCPS, BCCCP
Brian Iacoviello, PhD
From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Medical Industry FeatureFrom Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Charles Turck, PharmD, BCPS, BCCCP
Joseph Goldberg, MD
- advertisement
Neuroplasticity: A Potential Target for the Treatment of Depression
Medical Industry FeatureNeuroplasticity: A Potential Target for the Treatment of Depression
Charles Turck, PharmD, BCPS, BCCCP
Madhukar H. Trivedi, MD
Breakthrough Technology Improves Concussion Assessment and Player Safety
Medical Industry FeatureBreakthrough Technology Improves Concussion Assessment and Player Safety
Thomas S. Bottiglieri, DO
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry FeatureAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Marwan Sabbagh, MD, FAAN, CCR
Cara Leahy, DO
David Weisman, MD
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry FeatureAgitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
George Grossberg, MD
Angela Sanford, MD, CMD
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry FeatureTau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Yuval Zabar, MD
Michelle Mielke, PhD
Henrik Zetterberg, MD, PhD
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry FeatureTreating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
- advertisement
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Medical Industry FeatureAmyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Holly M. Brothers, PhD
Niklas Mattsson-Carlgren, MD, PhD
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry FeatureNew Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Brian Gill, M.D.
Reassessing the Full Clinical Picture of ADHD
Medical Industry FeatureReassessing the Full Clinical Picture of ADHD
Charles Turck, PharmD, BCPS, BCCCP
Ann Childress, MD
